OncoMed Pharma Stock Price (NASDAQ:OMED)

Add to My Stocks
$3.62 $0.04 (1.09%) OMED stock closing price Jul 25, 2017 (Closing)
Prev Close* : $3.66
Market Cap:
$137.7M
Day Low: $3.59
52 Week Low: $3.14
Open: $3.65
Volume: 94919
Day High: $3.7
52 Week High: $12.71
Dividend:
N/A

Latest Stock Market News

Latest Articles

OncoMed Pharma News - From Partners

OncoMed Announces Workforce Reduction   by Globe Newswire on Apr 24, 2017

OMED Stockcharts

View OMED PE ratio, PS ratio stocks charts and compare with peers.
OMED Chart
Note: Compare OncoMed Pharma stock price history with the index and industry peers.

OncoMed Pharma Valuation

PS ratio (
price to sales ratio
)
5.39

OncoMed Pharma Financial Ratios

Asset Turnover
0.14

OMED Industry Peers

Company Price Change (%)
Vivus (VVUS)1.180.02 (1.67%)
Fate Therapeutics (FATE)2.940.1 (3.29%)
Celgene (CELG)136.441.4 (1.02%)
Eli Lilly (LLY)82.192.55 (3.01%)
Bayer Ag (BAYRY)130.010.17 (0.13%)
Glaxosmithkline (GSK)41.960.28 (0.66%)
Verastem (VSTM)3.570.1 (2.72%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
Compugen (CGEN)4.050.65 (19.12%)
Idera Pharma (IDRA)2.060.14 (7.29%)
Merrimack Pharma (MACK)1.360.05 (3.82%)
PDL BioPharma (PDLI)2.460.08 (3.36%)
Horizon Pharma (HZNP)13.480.32 (2.43%)
Keryx Biopharma (KERX)7.450.16 (2.19%)
Acorda Therapeutics (ACOR)22.850.45 (2.01%)
Top gainers from Medical-Biomed-Genetics industry
* As of Jul 26, 2017
CompanyPriceChange (%)
Novavax (NVAX)1.10.41 (27.15%)
Dynavax Technologies (DVAX)9.90.75 (7.04%)
Vital Therapies (VTL)2.650.15 (5.36%)
EXACT Sciences (EXAS)37.332.11 (5.35%)
China Biologic Products (CBPO)98.325.05 (4.89%)
Epizyme (EPZM)12.650.65 (4.89%)
Trevena (TRVN)2.820.14 (4.73%)
Top losers from Medical-Biomed-Genetics industry
* As of Jul 26, 2017

Oncomed Pharmaceuticals Inc Stock News - Partner Headlines

OncoMed Pharma Financial Statements

income statement20162015201420132012
Net Sales Or Revenues25.15M25.89M39.55M37.77M24.68M
Net Income-103.1M-85.4M-50.01M-26.07M-22.23M
Total Operating Expense128.53M111.45M90.18M61.67M47.04M
view Oncomed Pharmaceuticals Inc income statement
balance sheet20162015201420132012
Total Assets195.48M237.88M247.84M333.68M79.76M
Total Liabilities218.51M234.33M171.47M215.56M41.22M
Shareholders Equity-23.02M3.55M76.36M118.12M38.54M
view Oncomed Pharmaceuticals Inc balance sheet
cash flow statement20162015201420132012
Net Increase (Decrease) In Assets Liabilities53.27M-2.13M-52.32M177.58M-13.22M
Net Cash From (Used By) Operating Activities-36.93M-75.13M-84.51M144.54M-33.34M
Increase (Decrease) In Prop Plant And Equipment-1.15M-1.36M-1.77M-0.55M-0.71M
view Oncomed Pharmaceuticals Inc cashflow statement

OncoMed Pharma Stock Message Board

An investor needs to spend 3.62 to buy OMED stock, as the closing OncoMed Pharma stock price is 3.62. The total market value as denoted by 137.7M for OncoMed Pharma, is the market value of the company's outstanding shares. OncoMed Pharma valuation can be different from its intrinsic stock price when viewed from a value investors perspective.

The terms stocks and shares mean the same thing. For Ex: OncoMed Pharma stock price and OncoMed Pharma share price mean the same thing. 94919 OMED shares were traded yesterday, and OncoMed Pharma stock chart shows that the OMED stock quote hit a day high of 3.7 and day low of 3.59. A dividend is a cash payment from a company's earnings and is distributed among shareholders. OncoMed Pharma does not pay dividends. To check the historical stock price movement, all time high, and all time low of OMED, view OncoMed Pharma stock price history.